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Accepted 25 August 2014; Published online 1 October 2014AbstractBackground and Objective: As systematic reviews may run out of date, it might be necessary to update them. Out-of-date reviews
may jeopardize the comparability when used in the context of overviews (review of reviews).
Methods: Seven electronic databases were searched for overviews up to November 2012. We first aimed to analyze whether the authors
of overviews additionally searched for primary studies or alternatively explained why they did not. Second, we sought to analyze the actual
publication lag (publication date of the overview  publication date of the review) in overviews and to develop recommendations for
authors of overviews.
Results: We included 147 overviews. The mean publication lag in overviews was more than 5 years. A median of 36% of the reviews
were published more than 6 years ago. Only one in four reviews considered up-to-dateness. The methods for updating reviews were
heterogeneous. We found no overview that systematically investigated whether an update was necessary.
Conclusion: The issue of up-to-dateness when conducting overviews seems to be neglected by most authors of overviews. Authors
should assess the quality of evidence, based on their included reviews first.  2014 Elsevier Inc.
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Open access under CC BY-NC-ND license.1. Introduction
Keeping current with the scientific literature is a very
challenging task for researchers but even more so for health
professionals as the amount of published literature in med-
ical science is rapidly rising. Eleven systematic reviews
(SRs) and 75 trials need to be read every day to keep up-
to-date, when just considering the publications listed in
MEDLINE [1].
This huge amount of literature has led reviewers to
perform evidence syntheses on reviews instead of primary
studies that are often called overviews (of reviews), review
of reviews, and umbrella reviews [2]. Overviews enable
the comparison of findings across conditions or interven-
tions and thus potentially provide answers to questions
for which a trial would never be performed. At the same
time, searching for reviews might be time saving as there
are fewer hits to screen and less data to extract comparedConflict of interest: None.
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Open access under CC BY-NC-ND license.with a synthesis of primary studies [3]. Although the num-
ber of published overviews is steadily increasing, there is
only little methodological guidance for conducting sound
overviews [4]. Many methodological issues have still not
been addressed.
If there is a need for updating the included reviews, one
of the methodological questions is related to updating
literature searches to keep them up-to-date [4]. There is
evidence that approximately 15%, 25%, and 50% of pub-
lished reviews are out-of-date after 1, 2, and 5.5 years,
respectively [5]. Including multiple SRs in an overview
inevitably poses the question of whether they are up-to-
date. This issue requires consideration especially when
they are not up-to-date as physicians and decision makers
are rather interested in the most current evidence. Howev-
er, our knowledge on how and when to update SRs is
scarce [6]. The ongoing scientific debate seems to concen-
trate on methods for identifying out-of-date reviews
[7e9]. Only 5% of overviews update their included SRs
by searching for additional primary studies [4]. The Co-
chrane Collaboration states that it is not necessary to
search for additional primary studies [10]. But as Co-
chrane reviews are usually updated on a regular basis,
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Key findings
 The mean publication lag per review was more
than 5 years.
 Only one in four overviews considered up-to-
dateness.
 No overview systematically investigated whether
an update was necessary.
What this adds to what was known?
 This is the first systematic analysis of up-to-
dateness in overviews.
 We developed recommendations to produce up-to-
date overviews.
What is the implication and what should change
now?
 Authors should analyze whether the underlying ev-
idence of systematic reviews (SRs) is still up-to-
date when conducting overviews.
 Authors should search for primary studies not
included in SRs, if needed
D. Pieper et al. / Journal of Clinicthe problem of out-of-date reviews is reduced. Some health
technology assessment (HTA) agencies showed that a num-
ber of agencies emphasized the need of additional searches
for primary studies, albeit this may be not necessary if there
is already enough evidence. Consequently, in the case that
not enough evidence exists, authors should search for addi-
tional primary studies.
To tackle this issue, we first aimed to analyze whether
the authors of overviews additionally searched for primary
studies or alternatively explained why they did not. Second,
we sought to analyze the actual publication lag in over-
views and to develop recommendations for authors of
overviews.2. Methods
2.1. Data sources and searches
To identify overviews, MEDLINE (via EMBASE),
EMBASE (via EMBASE), Cumulative Index to Nursing
and Allied Health Literature (via EBSCO), Physiotherapy
Evidence Database, and all databases of the Cochrane li-
brary (via the Cochrane library) were searched (see
Appendix A at www.jclinepi.com, for search strategies).
The last search was carried out in the beginning of
November 2012.2.2. Inclusion criteria
We included all overviews that synthesized reviews on
the same or a similar topic and/or intervention that were
derived through a systematic literature search. The authors
had to name at least one database and explicitly state that
they searched for reviews. We included overviews, irre-
spective of whether they also included primary studies
additionally. For inclusion, the evidence synthesis had to
rely at least in part on reviews (eg, combining primary
studies and reviews in the evidence synthesis). Further-
more, all included literature (either secondary or primary
research) must have been critically appraised. We excluded
all overviews with a methodological focus (eg, reviews
dealing with the reporting characteristics or quality of
SRs in a specific field). The articles had to be written in
English or German.2.3. Study selection
All titles and abstracts were screened independently. The
full texts of potentially eligible articles were then obtained
and assessed for eligibility against the review inclusion
criteria. All steps were performed independently by two re-
searchers. Any disagreements were resolved by discussion.2.4. Data extraction and analysis
The data were extracted by one reviewer in structured
summary tables and checked for accuracy by a second
reviewer. Any disagreements were resolved by consensus.
For each overview, we extracted data on
 The name of the first author
 The publication year of the overview and of all
included reviews
 The objective
 The number of the included reviews
 The number of the additionally included primary
studies (if any)
 Whether the authors searched for additional primary
studies
 Considering up-to-dateness of reviews (at least the
authors should acknowledge that the included reviews
might be outdated; in the case that authors searched
also for primary studies, we assumed that they
considered up-to-dateness; an explanation that more
research is unlikely to change the result in a signifi-
cant manner; a systematic assessment on whether an
update of the underlying reviews is necessary would
be a welcomed strategy. An evidence grading system
could be used to achieve this, for example.)
 The way they searched for primary studies [in paral-
lel/simultaneously (eg, one search strategy to identify
reviews and primary studies at the same time) or addi-
tional searches for primary studies (eg, one search
Potentially relevant overviews
identified and screened for retrieval
n = 5103
Overviews retrieved for more detailed 
evaluation 
n = 589
Excluded as abstract or title 
unsuitable
n = 4514
Overviews included in SR
n = 147
publications excluded from review n = 442
systematic literature search (n = 132)
critical appraisal (n = 229)
evidence synthesis (n = 11)
methodological focus (n = 5)
Written in English or German (n = 30)
full-text available (n = 35)
Fig. 1. Flow chart. SR, systematic review.
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strategy for primary studies)]
We generated the publication lag by subtracting the
publication year of an included review from the publica-
tion year of the overview. The mean publication lag was
calculated for each overview. Furthermore, following Sho-
jania et al. [5], we assumed that the probability for a re-
view to be out-of-date after 6 years is more than 50%.
Thus, we calculated the proportion of reviews in over-
views that were published 6 or more years before the
overview.Table 1. Overview characteristics
Category
Publication year
Number of included reviews
Considering up-to-dateness of reviews if not searching for primary studies
Searches for primary studies
Method of searching primary studies
Publication lag (yr)
Mean percentage of out-of-date reviews (6 yr)
Abbreviations: IQR, interquartile range; SD, standard deviation.
a Calculated from 30 of 117; reviews searching for primary studies wer3. Results
We identified 5,103 citations and included 147 overviews
in our review (Fig. 1). Appendix B at www.jclinepi.com lists
the included and excluded studies, along with the reasons for
exclusion. Table 1 summarizes the general overview
characteristics.
The number of included reviews in overviews ranged from
2 to 153 (median, 12; interquartile range, 6e26.75). The
mean publication lag per review was more than 5 years. This
is close to the 6-year range where more than half of the re-
views would be expected to be out of date [5]. The medianCharacteristic Number (%), N [ 147
2012 (up to November 2012) 25 (17)
2011 30 (20)
2010 30 (20)
2009 20 (14)
2008 11 (7)
2007 8 (5)
2006 6 (4)
2005 7 (5)
2004 3 (2)
2003 2 (1)
2002 0 (0)
2001 2 (1)
2000 1 (1)
1999 0 (0)
1998 1 (1)
Not reported 1 (1)
Median (IQR) 12 (6e27)
n (%) 30 (26)a
n (%) 30 (20)
Parallel, n (%) 24 (16)
Updates, n (%) 6 (4)
Mean (SD) 5.18 (2.06)
Median (IQR) 36 (1955)
e excluded from the denominator.
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was 35.72%. In addition to the inclusion of reviews, 30 over-
views (20.41%) also searched for primary studies. Two
different ways of searching for primary studies in overviews
can be distinguished.
In the first approach (6 of 30), the authors identified
reviews in a first step and then searched for additional
primary studies.
In the second approach, the authors searched for second-
ary and primary literature simultaneously. This was the
predominant way of searching for primary studies in our
analyzed overviews (24 of 30). However, there were many
ways to operationalize this. One used approach within par-
allel searches allows for the inclusion of primary studies
only if they were published after the search period of a cor-
responding review. In a second approach, authors performed
a ‘‘hierarchical evidence synthesis.’’ In a hierarchical evi-
dence synthesis, the authors begin with the highest level
of evidence according to the evidence pyramid (ie, search-
ing for reviews first) going down to lower ranked levels of
evidence placed below in the evidence pyramid [eg, ran-
domized controlled trials (RCTs), cohort studies] until the
best available evidence can be identified. This could also
mean that publications based on different levels of evidence
are included depending on the intervention, for example.
This might be the case if there is evidence from SRs for
one intervention, but there is only evidence from RCTs
for a second intervention for which no SR exists.
Subtracting the 30 overviews that also included primary
studies in addition to reviews, 30 of the remaining 117
overviews considered up-to-dateness (we assumed that
including additional primary studies is a strategy to
consider up-to-dateness). In contrast, overviews that also
searched for primary studies seldomly explained why they
updated the search, as well. Collectively, we found no over-
view that systematically investigated whether an update
was necessary. In the case of considering up-to-dateness,
we found authors mostly (n 5 16) stating the absence of
updating reviews to be a limitation of their work. An expla-
nation that more research is unlikely to change the result in
a significant manner was very rarely mentioned [11,12].
Almost one-tenth (14 of 148) of our analyzed overviews
used evidence grading systems. Anyway, we found no
author using the grading system to assess whether updating
reviews by searching for primary studies would be neces-
sary, albeit five (four in parallel and one updating) of them
searched for primary studies.4. Discussion
Our analyses showed that currently, there seems to be no
way to systematically investigate whether an update in the
context of overviews is necessary. More than one-third of
the included reviews in overviews are older than 5 years,
indicating a high risk of being not up-to-date. The issueof up-to-dateness of reviews was only considered in every
fourth review based on our analysis of 147 included
overviews.
Two different ways of searching for primary studies in
overviews were identified. On the one hand, authors
searched in parallel for reviews and primary studies. On
the other hand, authors performed additional searches for
primary studies after having inspected the included re-
views. Within the first approach (parallel searches), the idea
of ‘‘hierarchical evidence synthesis’’ will not update any
SR, but it might be worth investigating in overviews
comparing different interventions for a given condition if
there is no SR for one of the analyzed interventions. In gen-
eral, the idea of parallel searches allows for the inclusion of
primary studies only if they were published after the search
period of a corresponding SR. This approach will ensure
the up-to-dateness of the included reviews and provide an
actual impression of the evidence in the field of investiga-
tion provided that the updated review is of high quality
and is based on a comprehensive literature search. Updating
low-quality reviews that did not perform a comprehensive
search strategy by searching only the time span not covered
by the review (ie, searching after the search period of a cor-
responding SR) might be pointless if many studies were not
retrieved by the original search strategy. In this case, it
would probably be necessary to perform a new search that
is performed without any time restrictions.
It may also occur that more than one review for a spe-
cific question exists. However, it remains unclear how often
this issue might arise as slight variations in search strate-
gies, methods, populations, study designs, and outcomes
can make similar looking reviews diverse. Addressing the
issue of discordance, defined as conflicting results of
reviews on the same review question, may be one of the
major advantages of overviews, as it could help clinicians,
patients, and policy makers base their decisions on the
evidence most reliable and suitable to their situation.
Discordance is rarely dealt with in overviews [4]. Jadad
et al. [13] provide an algorithm that can help the authors
of overviews to resolve issues of discordance. Probably to
overcome this, some authors of our analyzed overviews
include only the most recent review in the case of multiple
reviews for a given question. In proceeding this way, they
would limit the period in which potentially new primary
studies were published. But this approach does not take
the quality of the reviews into account and thus cannot be
recommended as the most recent review might be of lower
quality than an older review. Producers of HTA reports
recommend only the inclusion of high-quality reviews
when conducting an overview [14e16].
In the second approach, the authors identified SRs in a
first step and then searched for additional primary studies.
Methods for updating SRs varied between the overviews.
A Cochrane overview used the search strategies of each
included SRs to update it [17], although the Cochrane
Collaboration states that it is not necessary to search for
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all authors of SRs report their search strategy. This was ful-
filled in this case as only Cochrane reviews were included.
Furthermore, a limited access to literature databases or
search interfaces (eg, OVID) will often impede authors of
overviews in proceeding this way to update SRs. If techni-
cally feasible, authors should assess the search strategies
with appropriate methods before using them [18,19].
An overview on early-life determinants of obesity did not
update all included SRs, but only the most recent SR for
each relevant risk factor [20]. Another overview explored
salt reduction in patients with hypertension [21]. Therein,
evidence was updated for the time frame after the most
recent SR. Arising problems related to this approach were
already mentioned. However, a possible bias was minimized
here as only high-quality SRs were included (scoring at least
five points on the Overview Quality Assessment Question-
naire [22,23]), although this does not necessarily mean that
these were based on a comprehensive search strategy.
If authors decided not to search for primary studies, we
would expect an explanation for this decision or at least a
reference on the fact that not updating SRs in overviews
may lead to out-of-date results. This was fulfilled by every
fourth overview.
An explanation that more research (ie, more primary
studies) is unlikely to change the result in an evidence syn-
thesis in a significant manner was very rarely mentioned.
Such a statement is highly welcome as it clarifies if impor-
tant findings from new primary research might have been
missed. If doing so, authors should clearly state how they
came to their conclusion. Such a conclusion could be
derived by investigating the whole body of evidence. Evi-
dence grading systems might be of high value here and
were already used in some of the included overviews.Fig. 2. Making overviHowever, some grading systems are based on the study
design alone without explicit consideration of other impor-
tant factors that play a major role in assessing the whole
body of evidence based on secondary research. This in-
cludes in particular the up-to-dateness of research findings.
Up-to-dateness of SRs is a prerequisite for sound over-
views. Updating the included SRs is time consuming but
will yield a current picture of the evidence. Our analysis
showed that authors of overviews do not systematically
deal with up-to-dateness. This is probably due to the
missing methodological guidance on how to update SRs
in the context of overviews. Thus, we provide some recom-
mendations for authors of overviews on what they should
consider and how they should proceed when conducting
high-quality overviews (Fig. 2).4.1. Assess quality of evidence
Assessing the quality of evidence (QoE) is the crucial
issue in all kinds of evidence syntheses. However, there
are some important points that should be taken into consid-
eration in the context of overviews. The critical appraisal of
the included SRs is an important part in conducting an
overview.
Primary studies might be included in more than one re-
view. Informal analysis by summing up results of reviews,
as we do in SRs of primary studies, could introduce signif-
icant overlap and double counting of evidence (primary
studies) leading to biased overview results. Methods for
calculating the degree of overlap have been recently pub-
lished [24]. For example, take into account two SRs on
the volumeeoutcome relationship in bariatric surgery
[25,26] that were investigated by us in an overview on
the hospital volumeeoutcome relationship in surgeryews up-to-date.
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review by Padwal is 2 years older than the review by Zevin.
All studies in the review by Padwal were also included in
the review by Zevin. Certainly, this is a glaring case of
overlapping reviews. We could only rely on the review by
Zevin and simply disregard the review by Padwal. But
when investigating the quality of both reviews, it becomes
apparent that the latter, the one that is probably more out of
date, is of higher methodological quality when applying the
Assessment of Multiple Systematic Reviews criteria [28].
It is important to note that even a number of additional
low-quality SRs for the same question may have no impact
on the QoE if there is high-quality evidence from at least
one SR.
It may occur that an update is necessary for some but not
for all aspects of an overview, depending on the research
question. A rationale for an overview might be to summa-
rize the evidence of different interventions for the same
condition, for instance [10]. This can lead to a situation
where we find a high QoE for one intervention but not
for the second. In this case, evidence should be only up-
dated for the second intervention.
Shekelle et al. [29] proposed a number of questions for
the assessment of the evidence basis. They could also be
taken into account when assessing QoE: Were any new in-
terventions or procedures introduced (including approvals
for new indications) that are possibly not covered by an
SR? Were there any alerts (ie, pharmaceuticals or medical
devices) or even market withdrawals? Has there been a
change in scope with respect to the outcomes or popula-
tion? Have new methodologies (eg, statistics) been intro-
duced that may change the conclusions of the SR or the
underlying studies? Authors should also consider whether
slight modifications in interventions or even more in prod-
ucts might have an influence on the evidence synthesis.
This is especially relevant for medical devices if new
devices are only slightly modified from a device that has
already been proven to be safe, for example. For example,
take into account the case of hip implants. Hip implants
are not required to undergo premarket testing. Manufac-
turers simply have to state that their hip implants are
similar to hip implants that have already been proven to
be safe. However, slight modification problems with new
hip implants still exist. Thus, it is very important to watch
out for new interventions or procedures when updating
reviews.
Unfortunately, to the best of our knowledge, there is no
established grading scheme for assessing the QoE based on
SRs instead of on primary studies, so it is not our intention
to condemn authors for not using a grading scheme. For
example, the Grading of Recommendations Assessment,
Development and Evaluation (GRADE) approach is one
of the most prominent grading schemes where the quality
of body of evidence, and not only individual studies, is
assessed [30]. However, this approach is not transferable
to overviews as some of the criteria are only applicableon the level of primary studies when assessing the body
of evidence. For example, the QoE can be uprated in the
case of large effect sizes. This could only be applied to
SRs with meta-analyses as narratively synthesized SRs do
not offer quantitative measures. Furthermore, publication
bias will be hard to assess at the level of SRs. There is a
need to develop a grading system that can also (or solely)
be applied to SRs in overviews. In accordance with
GRADE, the guiding idea for grading schemes should be
whether new research on a given topic is likely to change
the confidence in the estimate of the effect. This is the main
question authors should allow for when deciding whether
an update of the evidence is necessary in their overview.
A modification of GRADE so that it can be applied in over-
views as well would be pleasing and probably does make
more sense as many authors are already familiar with the
system. If authors do not want to use a grading system, they
should clearly report their reasons and state the reasons for
not analyzing the necessity of an update.
4.2. Limitations of our analysis
Our ad hoc descriptive analysis is explorative and has
some limitations, but it brings up a disregarded subject with
respect to overviews. Our results may be not comparable to
the analysis by Shojania et al. because of our broader inclu-
sion criteria without limiting the clinical area, for instance.
Furthermore, our analysis was also not only limited to
secondary research on randomized or quasi-randomized,
controlled trials. There were also a number of overviews
investigating risk factors where observational studies
played a major role. There is currently no evidence on
whether SRs of risk factors might be longer up-to-date as
they are probably not as much subject to new interventions
or enhanced procedures.
Because of the very large retrievals, we used a search
strategy focusing on words appearing in the title of the
article to increase precision, as we already did in a recent
article. Thus, we probably have not identified all published
overviews. However, it is unlikely that this would alter our
conclusions.
It was not our intention to provide the publication lag as
a (new) measure of up-to-dateness. It should be rather re-
garded as a descriptive measure as a part of an explorative
analysis as an overview will be as up-to-date as the newest
included review for that aspect of the overview.5. Conclusion
Up-to-dateness of SRs is a prerequisite for sound over-
views. We developed some recommendations for overviews
against the background that evidence syntheses should be
up-to-date as much as they can when they are published.
This issue seems to be neglected by most authors of over-
views. We suggest to focus on the assessment of the whole
body of evidence and not only the single SRs. If there is
1308 D. Pieper et al. / Journal of Clinical Epidemiology 67 (2014) 1302e1308more than one SR addressing the same research question,
these SRs should be regarded jointly. We encourage the
use of grading systems to assess the QoE in the body of ev-
idence. Future research should focus on grading systems
(among other methods) easily applicable to overviews. This
will help to make overviews more precise and valuable.
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